Description
Recombinant monoclonal antibody to Endosialin. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma Clone 8. This chimeric mouse antibody was made using the variable domain sequences of the original Rabbit IgG1 format, for improved compatibility with existing reagents, assays and techniques.
Target
Endosialin
Target Alias Names
CD248, TEM1, Tumor endothelial marker 1
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression